مروری بر درمان سندرم روده تحریک‌پذیر

Comments

Transcription

مروری بر درمان سندرم روده تحریک‌پذیر
Downloaded from journal.muq.ac.ir at 19:13 IRST on Wednesday October 12th 2016
(Review Article)
[email protected]
Rome III
Rome III
(Irritable Bowel Syndrome) IBS
Downloaded from journal.muq.ac.ir at 19:13 IRST on Wednesday October 12th 2016
Lactobacillus
Plantarum Bifidobacterium
IBS
IBS
IBS
Infantis
VSL#3
IBS
IBS
FDA
5-HT3
IBS-D
(Food and Drug Aminstration)
PEG
Downloaded from journal.muq.ac.ir at 19:13 IRST on Wednesday October 12th 2016
5-HT3
IBS
IBS
TCAS
IBS
IBS
TCAs
TCAs
IBS
TCA
IBS
IBS-D
IBS
IBS
TCAs
IBS
Sedation)
TCAs
IBS
5-HT4 4
SSRIs
5-HT4
5-HT4
SSRIs
Downloaded from journal.muq.ac.ir at 19:13 IRST on Wednesday October 12th 2016
SSRIs
SSRIs
IBS
SSRIs
SNRIs
Shift)
IBS
IBS
IBS
Sedation
.
CLC-2
IBS
IBS
IBS
C
CBT
IBS
IBS
GDH (Gut Directed Hypnotherapy)
IBS
Downloaded from journal.muq.ac.ir at 19:13 IRST on Wednesday October 12th 2016
IBS
IBS
IBS
Psychosocial)
IBS
IBS
IBS
Downloaded from journal.muq.ac.ir at 19:13 IRST on Wednesday October 12th 2016
IBS-C
IBS-D
References:
1. Drossman DA, Camilleri M, Mayer EA, Whitehead WE. AGA Technical Review on Irritable Bowel Syndrome.
Gastroenterology 2002;123:2108-2131.
2. Drossman DA, Cotazil ali E, Talley NJ, et al. Rome II: The Functional Gastrointestinal Disorders. 2nd ed. McLean VA:
Degnon; 2000.
3. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional Bowel Disorders. In: Drossman
DA, Corazziari E, Delvaux M, et al. editors. Rome III: The Functional Gastrointestinal Gisorders. 3rd ed. McLean. VA: Degnon;
2006. p. 487-555.
4. Talley N, Spiller RC. Irritable Bowel Syndrome: A Little Understood Organic Bowel Disease. Lancet 2002;360:555.
5. Mertz HR. Irritable Bowel Syndrome. N Engl J Med 2003;349:21-36.
6. Thompson WG. Review Article: The Treatment of Irritable Bowel Syndrome. Aliment Pharmacol Ther 2002;16:1395.
7. Davies GJ, Dettmar PW, Hoare RC. The Influence of Ispaghula Husk on Bowel Habit. JR Soc Health 1998;118:267 271.
8. Agah S, Ghadir MR, Abbasian A, et al. Lactase Deficiency and Bacterial Overgrowth in IBS Patient. Nezam Pezeshki
2008;26:36-41. [Full Text in Persian]
9. Food and Agriculture Organization of the United Nations and World Health Organization. Evaluation of Health and
Nutritional Properties of Powder Milk and Live Lactic Acid Bacteria. Geneva, Switz: Food and Agriculture Organization of the
United Nations and World Health Organization Expert Consultation Report; 2001.
10. Parker RP. Probiotics, The Other Half of The Atibitic Story. Anim Nutr Health 2003.
11. Schrezenmeir J, DeVrese M. Probiotic and Symbiotics-Approaching A Definition. Am J Clin 2005.
12. Agah S, Ghadir MR, Abbasian A, et al. Lactase Deficiency and Bacterial Overgrowth in IBS Patient. Nezam Pezeshki
2008;26:36-41. [Full Text in Persian]
13. Nobaek S, Johansson ML, Molin G, et al. Alteration of Intestinal Microflora is Associated with Reduction in Abdominal
Bloating and Pain in Patients with Irritable Bowel Syndrome. Am J Gastroenterol 2000;95:1237.
14. Kim HJ, Camilleri M, McKinzie S, et al. A Randomized Controlled Trial of a Probiotic, VSL#3, On Gut Transit and
Symptoms in Diarrhoea-Predominant Irritable Bowel Syndrome. Aliment Pharmacol Ther 2003;17:895.
15. Sen S, Mullan MM, Parker U, et al. Effect of Lactobacillusp Lantarum 299v on Colonic Fermentation and Symptoms of
Irritable Bowel Syndrome. Dig Dis Sci 2002;47:2615.
16. Brandt LJ, Prather CM, Quigley EM, Schiller LR, Schoenfeld P, Talley NJ. Systematic Review on the Management of
Chronic Constipation in North America. Am J Gastroenterol 2005;100:S5-S21.
17. Brandt L, Bjorkman D, Fennerty M, et al. An Evidence-Based Approach to the Management of Irritable Bowel Syndrome in
North America. Am J Gastroenterol 2002;97(Suppl):S7.
18. Kasper, Dennis L, Eugene Braunwald. Harrison s Principles Of Internal Medicine. 17th ed. USA: McGraw-Hill; 2008.
19. Mopelola A, Adeyemo, Lin Chang. New Treatment for Irritable Bowel Syndrome in Women, Review Article. Women s
Health 2008;4(6):605-623.
Downloaded from journal.muq.ac.ir at 19:13 IRST on Wednesday October 12th 2016
20. Hsieh C. Treatment of Constipation in Older Adults. Am Fam Physician 2005;2:277 2284.
21. Bosshard W, Dreher R, Schnegg JF, Bula CJ. The Treatment of Chronic Constipation in Elderly People: An Update. Drugs
Aging 2004;21:911-930.
22. Baker DE. Loperamide: A Pharmacological Review. Rev. Gastroenterol Disord 2007;7(Suppl 3):S11 S18.
23. Efskind PS, Bernklev T, Vatn MH. A Double-Blind Placebocontrolled Trial With Loperamide in Initable Bowel Syndrome.
Scand J Gastroenterol 1996;3l:463.
24. Lavo B, Stenstam M, Nielsen AL. Loperamide in Treatment of Irritable Bowel Syndrome: A Double-Blind PlaceboControlled Study. Scan J Gastroenterol Suppl 1987;130:77.
25. Crowell MD. The Role of Serotonin in the Pathophysiology of Irritable Bowel Syndrome. Am J Manag Care 2001;7:S252
S260.
26. Tonini M, Pace F. Drugs Acting on Serotonin Receptors for the Treatment of Functional GI Disorders. Dig Dis 2006;24:59-69.
27. Houghton LA, Foster JM, Whorwell PJ. Alosetron, A 5-HT3 Receptor Antagonist, Delays Colonic Transit in Patients with
Irritable Bowel Syndrome and Healthy Volunteers. Aliment Pharmacol Ther 2000;14:775-782.
28. Talley NJ. Antidepressantsin IBS: Are we Deluding Ourselves? Am J Gastroenterol 2004;99:921.
29. Su X, Gebhart GF. Effects of Tricyclic Antidepressants on Mechanosensitive Pelvic Nerve Afferent Fibers Innervating the
Rat Colon. Pain 1998;76:105-114.
30. Ghadir MR, Khademi H, Bakhshipur A. Comparison between Amitriptylin and Nortrytilin in Irritable Bowel Syndrome
Diarrhea Predominant Patient. Nezam Pezeshki 2008;IRI26:96-101. [Full Text in Persian]
31. Talley NJ: Evaluation of Drug Treatment in Irritable Bowel Syndrome. Br J Clin Pharmacol 2003;56:362.
32. Camil leri M, Bharucha AE, Ueno R, et al. Effect of a Selective Chloride Channel Activator, lubiprostone, on
Gastrointestinal Transit, Gastric Sensory, and Motor Functions in Healthy Volunteers. Am J Physiol. Gastrointest Liver Physiol
2006;290:G942-G947.
33. Johanson JF, Drossman DA, Panas R, Wahle A, Ueno R. Clinical Trial: Phase 2 Trial of Lubipro Stone for Irritable Bowel
Syndrome with Constipation. Aliment Pharmacol Ther 2008;27(8):685-696.
34. US FDA Approves New Prescription Drug for Adults for Treatment of Chronic Idiopathic Constipation. Avaliable From:
http://www.fda.gov/bbs/topics/news/2006/NEW01305.html. Accessed July 2008.
35. Andresen V, Camilleri M. Busciglio IA Effect of 5 Days Linaclotide on Transit and Bowel Function in Females with
Constipation-Predominant Irritable Bowel Syndrome. Gastroenterology 2007;133:761-768.
36. Bohn LM, Raehal KM. Opioid Receptor Signaling: Relevance for Gastrointestinal Therapy. Curr Opin Pharmacol
2006;6:559-563.
37. Berde C, Nurko S. Opioid Side Effects-Mechanism-Based Therapy. N Engl J Med 2008;358:2400-2402.
38. Lembo A. Peripheral Opioids for Functional GI Disease: A Reappraisal Dig Dis 2006;24:91-98.
39. Mangel AW, Bornstein JD, Hamm LR. Clinical Trial: Asimadoline in the Treatment of Patients with Irritable Bowel
Syndrome. Aliment Pharmacol Ther 2008;28:239-249.
40. Fischer H, Machen TE, Widdicombe JH, et al. A Novel Extract SB-300 from the Stem Bark Latex of Croton Lechleri
Inhibits CFTR-Mediated Chloride Secretion in Human Colonic Epithelial Cel Ls. J Ethnopharmacol 2004;93:351-357.
41. Pellow S, File SE. Is Tofisopam an Atypical Anxiolytic? Neurosci Biobehav Rev 1986;10:221-227.
42. Lackner JM, Jaccard J, Krasner SS, Katz LA , Gudleski GD, Hol Royd K. Self Administered Cognitive Behavior Therapy
for Moderate to Severe IBS: Clinical Efficacy, Tolerability, Feasibility. Clin Gastroenterol Hepatol 2008;6(8):899-906.
43. Drossman D, Camilleri M, Mayer E, Whitehead W. AGA Technical Review on Irritable Bowel Syndrome. Gastroenterology
2002;723:2108.
44. Whorwell PJ. Review Article: The History of Hypnotherapy and Its Role in the Irritable Bowel Syndrome. Aliment
Pharmacol Ther 2005;22:1061-1067.
45. Sato A, Sato Y, Suzuki A, Uchida S. Neural Mechanisms of the Reflex Inhibition and Excitation of Gastric Motility Elicited
by Acupuncture-like Stimulation in Anesthetized Rats. Neurosci Res 1993;18:53-62.
46. Jin JG, Mur Thy KS, Grider JR, Makhlouf GM. Stoichiometry of Neurally Induced VIP Release, NO Formation, and
Relaxation in Rabbit and Rat Gastric Muscle. Am J Physiol 1996;271:G357-G369.
Downloaded from journal.muq.ac.ir at 19:13 IRST on Wednesday October 12th 2016
47. Lim B, Manheimer E, Lao L, et al. Acupuncture for Treatment of Irritable Bowel Syndrome. Cochrane Database Syst Rev
2006;CD005111.
48. Liu JP, Yang M, Liu YX, Wei ML, Grimsgaard S. Herbal Medicines for Treatment of Irritable Bowel Syndrome. Cochrane
Database Syst Rev 2006;CD0 04116.
49. Vejdani R, Mohaghegh Shalmani HR, Mir-Fattahi M, et al. The Efficacy of an Herbal Medicine, Carmint, on the Relief of
Abdominal Pain and Bloating in Patient with Irritable Bowel Syndrome: A Pilot Study. Dig Dis Sci 2006;51:1501-1507.
50. Drossman DA, Camilleri M, Mayer EA, Whitehead WE. AGA Technical Review on Irritable Bowel Syndrome.
Gastroenterology 2002;123:2108-31.
51. Horwitz BJ, Fisher RS. The Irritable Bowel Syndrome. N Engl J Med 2001;344:1846-50.
52. Thompson WG. A Strategy for Management of the Irritable Bowel. Am J Gastroenterol 1986;81:95-100.
53. Jones J, Boorman J, Cann P, et al. British Society of Gastroenterology Guidelines for the Management of the Irritable Bowel
Syndrome. Gut 2000;47:Suppl 2:ii1-ii19.
Downloaded from journal.muq.ac.ir at 19:13 IRST on Wednesday October 12th 2016
This document was created with Win2PDF available at http://www.daneprairie.com.
The unregistered version of Win2PDF is for evaluation or non-commercial use only.

Similar documents